Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Multiple+sclerosis%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Multiple+sclerosis%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Multiple+sclerosis%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (6.000)
1
Long-term safety, tolerability and effectiveness study of ofatumumab in subjects with relapsing multiple sclerosis : An open-label, single arm, multi-center extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with relapsing multiple sclerosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients with Progressive Multiple Sclerosis : AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Hematopoietic Stem Cell Therapy for Patients with Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study : Hematopoietic Stem Cell Therapy for Patients with Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study - Hematopoietic Stem Cell Therapy for Inflammatory MS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Clarifying the mechanism of action of cladribine in relapsing multiple sclerosis : Clarifying the mechanism of action of cladribine in relapsing multiple sclerosis - ClaiMS, Cladribine in MS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients with Relapsing Forms of Multiple Sclerosis : A Two Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Teriflunomide Administered Orally Once Daily in Pediatric Patients with Relapsing Forms of Multiple Sclerosis Followed by an Open-Label Extension - TERIKIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients with Relapsing Forms of Multiple Sclerosis : A Two Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Teriflunomide Administered Orally Once Daily in Pediatric Patients with Relapsing Forms of Multiple Sclerosis Followed by an Open-Label Extension - TERIKIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A research study to look at the long term benefits and risks of ponesimod 20 mg treatment for patients with relapsing multiple sclerosis. : Multicenter, non-comparative extension to study AC-058B301, to investigate the long-term safety, tolerability, and control of disease of ponesimod 20 mg in subjects with relapsing multiple sclerosis - OPTIMUM LT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Study of Ocrelizumab in Comparison With Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis : A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sclerosis - OPERA II
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Clinical trial to determine the effect of Famciclovir on Epstein Barr virus levels in the saliva of patients with Multiple Sclerosis. : Clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in saliva of patients with Multiple Sclerosis. - Famciclovir in Multiple Sclerosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Safety and efficacy of fingolimod in pediatric patients with multiple sclerosis : A two-year, double-blind, randomized, multicenter, active controlled study to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon ß-1a i.m. once weekly in pediatric patients with multiple sclerosis with five-year fingolimod Extension Phase - PARADIGMS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[600]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
6.000
Aufsätze
6.000
E-Artikel
6.000
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
6.000
610
5.688
Study Type: Interventional
3.138
Recruitment Status: Not yet recruiting
1.728
Phase: Phase 3
1.108
Recruitment Status: Authorised-recruitment may ...
912
Recruitment Status: Completed
608
Recruitment Status: Recruiting
572
Phase: Phase 2
372
Phase: Phase 4
262
Study Type: Observational
154
Medical Condition: Multiple sclerosis. Multiple...
112
Medical Condition: Multiple Sclerosis. Multiple...
104
Medical Condition: ;G35 - Multiple sclerosis
104
Recruitment Status: Complete: follow-up complete
88
Medical Condition: Multiple sclerosis Nervous S...
78
Phase: Phase 2/Phase 3
72
Medical Condition: Multiple sclerosis MedDRA ve...
72
Medical Condition: Relapsing multiple sclerosis...
66
Medical Condition: Multiple sclerosis. Multiple...
54
Medical Condition: Multiple Sclerosis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.792
2020-
3.208
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.822
Englisch
116
Unbestimmt
38
Spanisch
16
Französisch
4
Deutsch
2
Dänisch
2
Niederländisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...